Tomohiro Katsumi

Yamagata, 9909585, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Real-World Outcomes of Combined Carbon-Ion Radiotherapy and Systemic Immunotherapy for Hepatocellular Carcinoma (Atezolizumab Plus Bevacizumab or Durvalumab Plus Tremelimumab): A Single-Center Retrospective Study.

Real-World Outcomes of Combined Carbon-Ion Radiotherapy and Systemic Immunotherapy for Hepatocellular Carcinoma (Atezolizumab Plus Bevacizumab or Durvalumab Plus Tremelimumab): A Single-Center Retrospective Study.

Journal: Journal of clinical medicine

Published: May 05, 2026

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: March 10, 2026

Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow-Up.

Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow-Up.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 04, 2026

Lyophilized mesenchymal stem cell-derived extracellular vesicles improve outcomes in acute liver failure models.

Lyophilized mesenchymal stem cell-derived extracellular vesicles improve outcomes in acute liver failure models.

Journal: American journal of physiology. Cell physiology

Published: January 16, 2026

Efficiency and Safety of Endoscopic Injection Sclerotherapy With Ligation for Esophageal Varices: A Retrospective Study.

Efficiency and Safety of Endoscopic Injection Sclerotherapy With Ligation for Esophageal Varices: A Retrospective Study.

Journal: DEN open

Published: January 14, 2026

Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.

Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia.

Journal: Hepatology international

Published: September 06, 2025

Treatment Outcomes in Patients Receiving Carbon-Ion Radiotherapy Versus Hepatectomy for Hepatocellular Carcinoma (≥4 cm): A Retrospective Study in Japan.

Treatment Outcomes in Patients Receiving Carbon-Ion Radiotherapy Versus Hepatectomy for Hepatocellular Carcinoma (≥4 cm): A Retrospective Study in Japan.

Journal: Journal of clinical medicine

Published: July 05, 2025

Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study.

Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study.

Journal: Cancers

Published: June 18, 2025

Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Journal: Cancers

Published: March 20, 2025

Safety and Effectiveness of Muse Cell Transplantation in a Large-Animal Model of Hepatic Fibrosis.

Safety and Effectiveness of Muse Cell Transplantation in a Large-Animal Model of Hepatic Fibrosis.

Journal: Stem cells international

Published: February 10, 2025

A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage.

A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage.

Journal: Cancer medicine

Published: January 24, 2025

Pipeline esophageal varices: Insights from clinical cases and models.

Pipeline esophageal varices: Insights from clinical cases and models.

Journal: DEN open

Published: October 16, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026